About W. Charles Conway
Get to Know Dr. W. Charles Conway
Dr. W. Charles Conway joined the Ridley-Tree Cancer Center in 2017 as director of surgical oncology, assembling its first multidisciplinary team to treat peritoneal malignancies such as mesothelioma.
He specializes in cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy, often called the HIPEC procedure. This is allowing many of his mesothelioma patients to resume normal lives after being diagnosed with this rare and often aggressive cancer caused by exposure to asbestos.
Conway treats a wide range of abdominal diseases, both malignant and benign, involving the pancreas, gall bladder, liver, bowel and esophagus. Many of his surgeries are minimally invasive procedures, including robotic surgery, which shorten recovery time.
Before joining the Ridley-Tree Cancer Center, Conway spent eight years at the Ochsner Cancer Center in New Orleans, where he performed the first totally robotic pancreaticoduodenectomy in state history.
The expansion of services at the Ridley-Tree Cancer Center — made possible by Conway’s arrival — has eliminated the need for patients to leave the Santa Barbara area to find the first-class, specialized care needed for complex peritoneal diseases.
Specialties of Dr. W. Charles Conway
Bile duct cancer
Dr. W. Charles Conway’s Experience and Medical Education
Ridley-Tree Cancer Center
Ochsner Cancer Center
Cedars-Sinai Medical Center (Fellowship)
John Wayne Cancer Institute (Fellowship)
Detroit Medical Center (Residency)
Wayne State University School of Medicine (MD)
American Board of Surgery (Certification)
Awards and Other Recognitions
Outstanding Clinical Faculty Award
Castle Connolly Regional Top Doctor
American Society of Clinical Oncology (Member)
2018 Donor Acknowledgement
Get a Free Mesothelioma Guide
Free information, books, wristbands and more for patients and caregivers.
Dr. W. Charles Conway is a Mesothelioma Expert
Conway believes that finding a cancer specialty center with the experience his staff brings is critical to surviving a diagnosis of mesothelioma.
The intricate cytoreductive surgery, combined with HIPEC, is a procedure that can take up to 12 hours in the operating room, leading to a long but successful recovery.
“These mesothelioma patients are in a tough spot, but you can make a difference for them with hard work and the experience we have,” Conway said. “It’s a difficult operation, and the post-operative care is difficult. But we are well-equipped to handle it here.”
Publications of Dr. W. Charles Conway
Bolton, N. et al. (2019, April 21). Multi-agent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer. HPB (Oxford): Journal of the International Hepato-Pancreato-Biliary Association.
Bolton, J., Conway, W.C. (2011, October). Postgastrectomy Syndromes. The Surgical Clinics of North America.
Conway, W.C., Bolton, J.S. (2011, March). Surgical Treatment of Pancreatic Cancer. Journal of Louisiana State Medical Society.
Disclaimer: Dr. W. Charles Conway has no professional affiliation with Asbestos.com.
1 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Thank you for your feedback. Would you like to speak with a Patient Advocate?
Share this article
Last Modified June 1, 2020